Zurich Cantonal Bank
RPTX

Zurich Cantonal Bank’s Repare Therapeutics RPTX Stock Holding History

Zurich Cantonal Bank’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,474
Closed -$31K – 2819
2021
Q4 		$31K Sell
1,474
-150
-9% -$3.53K ﹤0.01% 2821
2021
Q3 		$43K Buy
1,624
+31
+2% +$1K ﹤0.01% 2657
2021
Q2 		$50K Buy
1,593
+94
+6% +$3.08K ﹤0.01% 2448
2021
Q1 		$46K Buy
+1,499
New +$50.9K ﹤0.01% 2408

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Zurich Cantonal Bank's RPTX Position: Q1 2022 in Review

Zurich Cantonal Bank sold out of Repare Therapeutics (RPTX) in Q1 2022, closing a stake of 1,474 shares — an estimated $31K sold.

Zurich Cantonal Bank first reported a position in RPTX in Q1 2021 and held it in 4 quarters. The position peaked at $50K in Q2 2021. 62 funds tracked by Wall St. Rank hold RPTX as of Q1 2022.

  • Zurich Cantonal Bank reported no remaining Repare Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,474 Repare Therapeutics shares in Q1 2022, an estimated $31K.
  • Zurich Cantonal Bank first reported a position in Repare Therapeutics in Q1 2021 and held it in 4 quarters.
  • Zurich Cantonal Bank's Repare Therapeutics position peaked at $50K in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2022.

Based on Zurich Cantonal Bank's 13F filing for Q1 2022, filed 21 Apr 2022.